MedTrace Logo

Effects of Walnuts on Endothelial Function in Overweight Adults With at Least One Factor of Metabolic Syndrome

NCT01413646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-08-02

No results posted yet for this study

Summary

The purpose of this study is to examine the effects of walnut consumption on endothelial function and lipid markers in overweight patients with at least one factor of metabolic syndrome as compared to the control group.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Walnut Supplementation

Eight weeks of walnut supplementation

DIETARY_SUPPLEMENT

No walnut supplementation

Eight weeks without walnut supplementation

Sponsors & Collaborators

  • California Walnut Commission

    collaborator OTHER

  • Griffin Hospital

    lead OTHER

Principal Investigators

  • David L. Katz, MD, MPH · Yale-Griffin Prevention Research Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-10-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01413646 on ClinicalTrials.gov